Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Cash from Investing Activities (2016 - 2022)

Nephros (NEPH) has 8 years of Cash from Investing Activities data on record, last reported at -$103000.0 in Q2 2022.

  • For Q2 2022, Cash from Investing Activities changed N/A year-over-year to -$103000.0; the TTM value through Sep 2024 reached -$103000.0, changed N/A, while the annual FY2024 figure was -$50000.0, 33.33% up from the prior year.
  • Cash from Investing Activities reached -$103000.0 in Q2 2022 per NEPH's latest filing, down from -$34000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$13000.0 in Q3 2020 and bottomed at -$137000.0 in Q1 2019.
  • Average Cash from Investing Activities over 4 years is -$55142.9, with a median of -$34000.0 recorded in 2022.
  • Peak YoY movement for Cash from Investing Activities: increased 7.14% in 2020, then crashed 376.92% in 2021.
  • A 4-year view of Cash from Investing Activities shows it stood at -$14000.0 in 2019, then rose by 7.14% to -$13000.0 in 2020, then plummeted by 376.92% to -$62000.0 in 2021, then plummeted by 66.13% to -$103000.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$103000.0 in Q2 2022, -$34000.0 in Q1 2022, and -$62000.0 in Q3 2021.